Englesbe Michael J, Dubay Derek A, Wu Audrey H, Pelletier Shawn J, Punch Jeffery D, Franz Michael G
Department of Surgery, Section of General Surgery, and the Department of Internal Medicine, Section of Cardiology, University of Michigan Health System, Ann Arbor 48109-0331, USA.
Arch Surg. 2005 Apr;140(4):399-403; discussion 404. doi: 10.1001/archsurg.140.4.399.
Preemptive cholecystectomy in cardiac transplant patients with radiographic biliary pathology reduces the morbidity and mortality of biliary tract disease following heart transplantation compared with expectant management.
Institutional survey at the University of Washington, Seattle.
Cardiac transplant recipients between January 1, 1992, and January 1, 2001. Main Outcome Measure Clinical course of patients who were diagnosed as having biliary tract disease following heart transplantation and were managed expectantly (observed) compared with the course of patients whose conditions were diagnosed and who underwent an operation.
Sixty (35.7%) of 168 cardiac transplant patients were evaluated for biliary tract pathologic condition. Of the 71.7% (43 of 60 patients) who had an abnormal radiographic evaluation, 46.5% (20 patients) had surgery on their biliary tract while the other patients were observed. Nine of the 23 patients who were followed up expectantly had cholelithiasis, 7 patients had gallbladder wall thickening, 5 patients had sludge in their gallbladder, and 2 had biliary dilatation. These patients were followed up for a mean +/- SD of 3.7 +/- 1.3 years; none developed biliary tract symptoms during this period. Cholecystectomies were completed for both emergent (7) and elective (14) indications. The mean +/- SD length of stay for patients who had emergent operations was 24.3 +/- 11.2 days, compared with 3.2 +/- 2.8 days for the patients who had elective operations. Seven (33%) of the 21 patients who had an operation had a significant complication and 1 patient died.
These data suggest that the morbidity of an elective cholecystectomy in cardiac transplant patients is significant and equivalent to the morbidity associated with emergent procedures. Expectant management of patients with radiographic evidence of biliary tract pathology discovered after transplantation was safe in this series.
与保守治疗相比,对有影像学胆道病变的心脏移植患者进行预防性胆囊切除术可降低心脏移植后胆道疾病的发病率和死亡率。
华盛顿大学西雅图分校的机构调查。
1992年1月1日至2001年1月1日期间的心脏移植受者。主要观察指标:心脏移植后被诊断为患有胆道疾病并接受保守治疗(观察)的患者的临床病程,与被诊断并接受手术的患者的病程进行比较。
168例心脏移植患者中有60例(35.7%)接受了胆道病变评估。在影像学评估异常的71.7%(60例中的43例)患者中,46.5%(20例)接受了胆道手术,其余患者接受观察。23例接受保守治疗的患者中,9例有胆结石,7例胆囊壁增厚,5例胆囊有胆泥,2例有胆道扩张。这些患者的平均随访时间为3.7±1.3年;在此期间均未出现胆道症状。胆囊切除术根据急诊(7例)和择期(14例)指征完成。急诊手术患者的平均住院时间为24.3±11.2天,择期手术患者为3.2±2.8天。21例接受手术的患者中有7例(33%)出现严重并发症,1例死亡。
这些数据表明,心脏移植患者择期胆囊切除术的发病率较高,且与急诊手术的发病率相当。在本系列研究中,对移植后发现有影像学胆道病变证据的患者进行保守治疗是安全的。